{
  "id": "guillain-barre-syndrome",
  "title": "Guillain-Barré Syndrome",
  "version": "1.0",
  "icd10": [
    "** G61.0 (Guillain-Barré syndrome)"
  ],
  "scope": "** Evaluation and management of acute Guillain-Barré Syndrome in adults, including all major variants (AIDP, AMAN, AMSAN, Miller Fisher). Covers respiratory monitoring protocols, immunotherapy (IVIg and plasmapheresis), autonomic dysfunction management, and ICU care. Excludes CIDP (chronic inflammatory demyelinating polyneuropathy) and pediatric GBS.",
  "notes": [],
  "sections": {
    "Laboratory Workup": {
      "Essential/Core Labs": [
        {
          "item": "CBC with differential",
          "rationale": "Baseline, infection screen",
          "target": "Normal or mild leukocytosis",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "CMP (BMP + LFTs)",
          "rationale": "Electrolytes, renal function for IVIg",
          "target": "Normal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Magnesium",
          "rationale": "Hypomagnesemia worsens weakness",
          "target": ">1.8 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Phosphorus",
          "rationale": "Hypophosphatemia causes weakness",
          "target": ">2.5 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "ESR, CRP",
          "rationale": "Inflammatory markers",
          "target": "May be mildly elevated",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Urinalysis",
          "rationale": "UTI as trigger",
          "target": "Document",
          "ED": "STAT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Blood glucose",
          "rationale": "Hyperglycemia worsens outcomes",
          "target": "<180 mg/dL",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "TSH",
          "rationale": "Thyroid myopathy in differential",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "CPK",
          "rationale": "Myopathy in differential",
          "target": "Normal or mildly elevated",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "PT/INR, PTT",
          "rationale": "Pre-LP, pre-PLEX",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Extended Workup": [
        {
          "item": "Anti-ganglioside antibodies (GM1, GD1a, GD1b, GQ1b)",
          "rationale": "Variant classification, prognosis",
          "target": "Document positivity",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Campylobacter jejuni serology",
          "rationale": "Most common trigger",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "CMV IgM/IgG",
          "rationale": "Viral trigger",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "EBV panel",
          "rationale": "Viral trigger",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Mycoplasma pneumoniae IgM",
          "rationale": "Bacterial trigger",
          "target": "Document if positive",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "HIV",
          "rationale": "HIV-associated GBS",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Hepatitis B surface antigen",
          "rationale": "Pre-IVIg screening",
          "target": "Negative",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Hepatitis C antibody",
          "rationale": "Pre-PLEX screening",
          "target": "Negative",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "COVID-19 PCR/antigen",
          "rationale": "COVID-associated GBS",
          "target": "Document",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Quantitative immunoglobulins",
          "rationale": "IgA deficiency (IVIg contraindication)",
          "target": "IgA >7 mg/dL",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Type and screen",
          "rationale": "Pre-PLEX",
          "target": "Available",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Zika virus serology",
          "rationale": "Travel to endemic area",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "West Nile virus serology",
          "rationale": "Endemic area, summer months",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Lyme serology",
          "rationale": "Endemic area, tick exposure",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Porphyrins (urine)",
          "rationale": "Motor neuropathy with abdominal pain",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Heavy metals (lead, arsenic, thallium)",
          "rationale": "Toxic neuropathy differential",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Serum protein electrophoresis",
          "rationale": "Paraproteinemic neuropathy",
          "target": "Normal",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Anti-acetylcholine receptor antibodies",
          "rationale": "MG in differential",
          "target": "Negative",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        }
      ],
      "Lumbar Puncture": [
        {
          "item": "Opening pressure",
          "rationale": "Exclude elevated ICP",
          "target": "Normal (10-20 cmH2O)",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Cell count (tubes 1 and 4)",
          "rationale": "Albuminocytologic dissociation",
          "target": "WBC <10 (usually <5)",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Protein",
          "rationale": "Elevated in GBS",
          "target": "Elevated (>45 mg/dL; often >100)",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Glucose",
          "rationale": "Exclude infection",
          "target": "Normal",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Gram stain and culture",
          "rationale": "Exclude bacterial meningitis",
          "target": "Negative",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Cytology",
          "rationale": "If malignancy suspected",
          "target": "Negative",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Oligoclonal bands",
          "rationale": "Atypical cases",
          "target": "Usually negative (positive in <10%)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ]
    },
    "Imaging & Studies": {
      "Essential/First-line": [
        {
          "item": "Chest X-ray",
          "timing": "On admission",
          "target": "Aspiration, atelectasis",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "ECG",
          "timing": "On admission",
          "target": "Autonomic dysfunction (arrhythmia)",
          "contraindications": "None",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Forced vital capacity (FVC)",
          "timing": "Serial q4-6h",
          "target": "FVC >20 mL/kg (stable)",
          "contraindications": "Facial weakness limiting seal",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Negative inspiratory force (NIF)",
          "timing": "Serial q4-6h",
          "target": "NIF more negative than -30 cmH2O",
          "contraindications": "Facial weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Nerve conduction studies/EMG",
          "timing": "Within 48-72 hours",
          "target": "Demyelination, conduction block",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        }
      ],
      "Extended": [
        {
          "item": "MRI spine with contrast",
          "timing": "If diagnostic uncertainty",
          "target": "Nerve root enhancement (spinal roots)",
          "contraindications": "Pacemaker, hemodynamic instability",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "MRI brain with contrast",
          "timing": "Miller Fisher variant",
          "target": "Cranial nerve enhancement",
          "contraindications": "Pacemaker",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Swallow evaluation",
          "timing": "If bulbar weakness",
          "target": "Aspiration risk",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Echocardiogram",
          "timing": "If autonomic instability",
          "target": "Takotsubo, cardiac dysfunction",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Rare/Specialized": [
        {
          "item": "Repetitive nerve stimulation",
          "timing": "If MG suspected",
          "target": "Normal (vs decrement in MG)",
          "contraindications": "None",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        },
        {
          "item": "Autonomic function testing",
          "timing": "Persistent dysautonomia",
          "target": "Abnormal heart rate variability",
          "contraindications": "Unstable patient",
          "ED": "—",
          "HOSP": "EXT",
          "OPD": "—",
          "ICU": "EXT"
        }
      ]
    },
    "Treatment": {
      "Acute/Emergent - Respiratory Support": [
        {
          "item": "Supplemental oxygen",
          "route": "INH",
          "indication": "Hypoxemia",
          "dosing": {
            "doseOptions": [
              {
                "text": "2-6 L/min NC",
                "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
              },
              {
                "text": "15 L/min NRB",
                "orderSentence": "Supplemental oxygen 15 L/min NRB INH"
              }
            ],
            "route": "INH",
            "instructions": "Titrate to O2 sat >94%; escalate to high-flow if needed",
            "orderSentence": "Supplemental oxygen 2-6 L/min NC INH"
          },
          "contraindications": "None",
          "monitoring": "O2 sat, RR",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Endotracheal intubation",
          "route": "—",
          "indication": "Respiratory failure",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Endotracheal intubation N/A —"
              }
            ],
            "route": "—",
            "instructions": "Intubate if FVC <20 mL/kg, NIF >-30 cmH2O, or clinical deterioration; avoid succinylcholine (hyperkalemia risk)",
            "orderSentence": "Endotracheal intubation N/A —"
          },
          "contraindications": "—",
          "monitoring": "ETT position, ventilator settings",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Mechanical ventilation",
          "route": "—",
          "indication": "Respiratory failure",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Mechanical ventilation N/A —"
              }
            ],
            "route": "—",
            "instructions": "Lung-protective ventilation; TV 6-8 mL/kg IBW; PEEP 5-8 cmH2O",
            "orderSentence": "Mechanical ventilation N/A —"
          },
          "contraindications": "—",
          "monitoring": "ABG, ventilator parameters",
          "ED": "—",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Immunotherapy - First-line": [
        {
          "item": "IVIg (immune globulin IV) - 5-day protocol",
          "route": "IV",
          "indication": "Primary immunotherapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg/day x 5 days",
                "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
              }
            ],
            "route": "IV",
            "instructions": "0.4 g/kg/day IV for 5 days (total 2 g/kg); infuse slowly day 1 (start 0.5-1 mL/kg/hr, advance to max 4 mL/kg/hr)",
            "orderSentence": "IVIg (immune globulin IV) - 5-day protocol 0.4 g/kg/day x 5 days IV"
          },
          "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
          "monitoring": "Renal function, headache, infusion reactions; pre-medicate with acetaminophen/diphenhydramine",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "IVIg (immune globulin IV) - 2-day protocol",
          "route": "IV",
          "indication": "Primary immunotherapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "1 g/kg/day x 2 days",
                "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
              }
            ],
            "route": "IV",
            "instructions": "1 g/kg/day IV for 2 days (total 2 g/kg); alternative accelerated protocol; same total dose",
            "orderSentence": "IVIg (immune globulin IV) - 2-day protocol 1 g/kg/day x 2 days IV"
          },
          "contraindications": "IgA deficiency (<7 mg/dL) with anti-IgA antibodies; severe renal impairment",
          "monitoring": "Renal function, headache, infusion reactions; higher daily dose may increase infusion reactions",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Plasmapheresis (PLEX)",
          "route": "—",
          "indication": "Primary immunotherapy",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 exchanges over 1-2 weeks",
                "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
              }
            ],
            "route": "—",
            "instructions": "5 exchanges (200-250 mL/kg per exchange) over 7-14 days; typically QOD",
            "orderSentence": "Plasmapheresis (PLEX) 5 exchanges over 1-2 weeks —"
          },
          "contraindications": "Hemodynamic instability; severe sepsis; IV access issues",
          "monitoring": "BP, electrolytes (Ca, Mg, K), coagulation, fibrinogen",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Autonomic Dysfunction Management": [
        {
          "item": "Normal saline",
          "route": "IV",
          "indication": "Hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "250 mL",
                "orderSentence": "Normal saline 250 mL IV"
              },
              {
                "text": "500 mL",
                "orderSentence": "Normal saline 500 mL IV"
              },
              {
                "text": "1000 mL",
                "orderSentence": "Normal saline 1000 mL IV"
              }
            ],
            "route": "IV",
            "instructions": "250-500 mL bolus for SBP <90; avoid overhydration",
            "orderSentence": "Normal saline 250 mL IV"
          },
          "contraindications": "Heart failure",
          "monitoring": "BP, I/O, JVD",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Phenylephrine",
          "route": "IV",
          "indication": "Refractory hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "100-200 mcg bolus",
                "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
              },
              {
                "text": "0.5-2 mcg/kg/min",
                "orderSentence": "Phenylephrine 0.5-2 mcg/kg/min IV"
              }
            ],
            "route": "IV",
            "instructions": "Start 0.5 mcg/kg/min; titrate to MAP >65",
            "orderSentence": "Phenylephrine 100-200 mcg bolus IV"
          },
          "contraindications": "Severe bradycardia",
          "monitoring": "Continuous BP, HR",
          "ED": "—",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Esmolol",
          "route": "IV",
          "indication": "Hypertensive crisis",
          "dosing": {
            "doseOptions": [
              {
                "text": "500 mcg/kg load",
                "orderSentence": "Esmolol 500 mcg/kg load IV"
              },
              {
                "text": "50-200 mcg/kg/min",
                "orderSentence": "Esmolol 50-200 mcg/kg/min IV"
              }
            ],
            "route": "IV",
            "instructions": "Load 500 mcg/kg over 1 min, then 50-200 mcg/kg/min; short-acting preferred in GBS",
            "orderSentence": "Esmolol 500 mcg/kg load IV"
          },
          "contraindications": "Bradycardia, heart block, decompensated HF",
          "monitoring": "HR, BP",
          "ED": "—",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Atropine",
          "route": "IV",
          "indication": "Symptomatic bradycardia",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.5 mg",
                "orderSentence": "Atropine 0.5 mg IV"
              },
              {
                "text": "1 mg",
                "orderSentence": "Atropine 1 mg IV"
              }
            ],
            "route": "IV",
            "instructions": "0.5-1 mg IV push for HR <50 with symptoms; may repeat q3-5min; max 3 mg",
            "orderSentence": "Atropine 0.5 mg IV"
          },
          "contraindications": "Tachycardia",
          "monitoring": "HR, rhythm",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Temporary pacing",
          "route": "—",
          "indication": "Complete heart block",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Temporary pacing N/A —"
              }
            ],
            "route": "—",
            "instructions": "Transcutaneous or transvenous pacing for refractory bradycardia/asystole",
            "orderSentence": "Temporary pacing N/A —"
          },
          "contraindications": "—",
          "monitoring": "Continuous telemetry",
          "ED": "—",
          "HOSP": "—",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Fludrocortisone",
          "route": "PO",
          "indication": "Orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.1 mg daily",
                "orderSentence": "Fludrocortisone 0.1 mg daily PO"
              },
              {
                "text": "0.2 mg daily",
                "orderSentence": "Fludrocortisone 0.2 mg daily PO"
              }
            ],
            "route": "PO",
            "instructions": "0.1-0.2 mg PO daily for persistent orthostatic hypotension",
            "orderSentence": "Fludrocortisone 0.1 mg daily PO"
          },
          "contraindications": "Hypertension, heart failure",
          "monitoring": "BP (supine and standing), edema, K+",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Midodrine",
          "route": "PO",
          "indication": "Orthostatic hypotension",
          "dosing": {
            "doseOptions": [
              {
                "text": "2.5 mg TID",
                "orderSentence": "Midodrine 2.5 mg TID PO"
              },
              {
                "text": "5 mg TID",
                "orderSentence": "Midodrine 5 mg TID PO"
              },
              {
                "text": "10 mg TID",
                "orderSentence": "Midodrine 10 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 2.5-5 mg TID; max 10 mg TID; avoid evening dose",
            "orderSentence": "Midodrine 2.5 mg TID PO"
          },
          "contraindications": "Supine hypertension, urinary retention",
          "monitoring": "BP (supine and standing)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Symptomatic/Supportive Care": [
        {
          "item": "Gabapentin",
          "route": "PO",
          "indication": "Neuropathic pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "300 mg qHS",
                "orderSentence": "Gabapentin 300 mg qHS PO"
              },
              {
                "text": "300 mg TID",
                "orderSentence": "Gabapentin 300 mg TID PO"
              },
              {
                "text": "600 mg TID",
                "orderSentence": "Gabapentin 600 mg TID PO"
              },
              {
                "text": "900 mg TID",
                "orderSentence": "Gabapentin 900 mg TID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 300 mg qHS; titrate by 300 mg/day q1-3d; max 3600 mg/day in 3 divided doses",
            "orderSentence": "Gabapentin 300 mg qHS PO"
          },
          "contraindications": "Severe renal impairment (adjust dose)",
          "monitoring": "Sedation, dizziness; reduce dose if CrCl <60",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Pregabalin",
          "route": "PO",
          "indication": "Neuropathic pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "75 mg BID",
                "orderSentence": "Pregabalin 75 mg BID PO"
              },
              {
                "text": "150 mg BID",
                "orderSentence": "Pregabalin 150 mg BID PO"
              },
              {
                "text": "300 mg BID",
                "orderSentence": "Pregabalin 300 mg BID PO"
              }
            ],
            "route": "PO",
            "instructions": "Start 75 mg BID; may increase to 150 mg BID after 1 week; max 600 mg/day",
            "orderSentence": "Pregabalin 75 mg BID PO"
          },
          "contraindications": "Severe renal impairment (adjust dose)",
          "monitoring": "Sedation, edema, weight gain",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Morphine",
          "route": "IV",
          "indication": "Severe pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "2 mg q4h PRN",
                "orderSentence": "Morphine 2 mg q4h PRN IV"
              },
              {
                "text": "4 mg q4h PRN",
                "orderSentence": "Morphine 4 mg q4h PRN IV"
              }
            ],
            "route": "IV",
            "instructions": "2-4 mg IV q4h PRN for severe pain; use cautiously with respiratory compromise",
            "orderSentence": "Morphine 2 mg q4h PRN IV"
          },
          "contraindications": "Respiratory depression",
          "monitoring": "RR, sedation, O2 sat",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Enoxaparin",
          "route": "SC",
          "indication": "DVT prophylaxis",
          "dosing": {
            "doseOptions": [
              {
                "text": "40 mg daily",
                "orderSentence": "Enoxaparin 40 mg daily SC"
              },
              {
                "text": "30 mg BID",
                "orderSentence": "Enoxaparin 30 mg BID SC"
              }
            ],
            "route": "SC",
            "instructions": "40 mg SC daily (BMI <40) or 30 mg BID (BMI >40); hold if CrCl <30; **HOLD if LP planned within 12 hours**",
            "orderSentence": "Enoxaparin 40 mg daily SC"
          },
          "contraindications": "Active bleeding, HIT, CrCl <30 (use UFH), pending LP",
          "monitoring": "Platelet count, signs of bleeding",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Heparin (UFH)",
          "route": "SC",
          "indication": "DVT prophylaxis (renal impairment)",
          "dosing": {
            "doseOptions": [
              {
                "text": "5000 units q8h",
                "orderSentence": "Heparin (UFH) 5000 units q8h SC"
              },
              {
                "text": "5000 units q12h",
                "orderSentence": "Heparin (UFH) 5000 units q12h SC"
              }
            ],
            "route": "SC",
            "instructions": "5000 units SC q8-12h if CrCl <30; **HOLD if LP planned within 4-6 hours**",
            "orderSentence": "Heparin (UFH) 5000 units q8h SC"
          },
          "contraindications": "Active bleeding, HIT, pending LP",
          "monitoring": "Platelet count, signs of bleeding",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "SCDs (sequential compression devices)",
          "route": "—",
          "indication": "DVT prophylaxis",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "SCDs (sequential compression devices) N/A —"
              }
            ],
            "route": "—",
            "instructions": "Bilateral lower extremity SCDs; use in addition to pharmacologic prophylaxis",
            "orderSentence": "SCDs (sequential compression devices) N/A —"
          },
          "contraindications": "Acute DVT in that extremity",
          "monitoring": "Skin integrity",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Bisacodyl",
          "route": "PO/PR",
          "indication": "Constipation (autonomic)",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg daily",
                "orderSentence": "Bisacodyl 10 mg daily PO/PR"
              },
              {
                "text": "10 mg suppository",
                "orderSentence": "Bisacodyl 10 mg suppository PO/PR"
              }
            ],
            "route": "PO/PR",
            "instructions": "10 mg PO or PR daily as needed",
            "orderSentence": "Bisacodyl 10 mg daily PO/PR"
          },
          "contraindications": "Bowel obstruction",
          "monitoring": "Bowel movements",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Polyethylene glycol",
          "route": "PO",
          "indication": "Constipation (autonomic)",
          "dosing": {
            "doseOptions": [
              {
                "text": "17 g daily",
                "orderSentence": "Polyethylene glycol 17 g daily PO"
              },
              {
                "text": "17 g BID",
                "orderSentence": "Polyethylene glycol 17 g BID PO"
              }
            ],
            "route": "PO",
            "instructions": "17 g (1 capful) PO daily-BID; titrate to 1-2 BMs daily",
            "orderSentence": "Polyethylene glycol 17 g daily PO"
          },
          "contraindications": "Bowel obstruction",
          "monitoring": "Bowel movements",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Metoclopramide",
          "route": "IV/PO",
          "indication": "Gastroparesis",
          "dosing": {
            "doseOptions": [
              {
                "text": "10 mg q6h AC",
                "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
              }
            ],
            "route": "IV/PO",
            "instructions": "10 mg IV/PO before meals and at bedtime; max 40 mg/day; limit to 5 days",
            "orderSentence": "Metoclopramide 10 mg q6h AC IV/PO"
          },
          "contraindications": "Parkinson disease, GI obstruction",
          "monitoring": "EPS, tardive dyskinesia",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Ondansetron",
          "route": "IV/PO",
          "indication": "Nausea",
          "dosing": {
            "doseOptions": [
              {
                "text": "4 mg q6h PRN",
                "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
              },
              {
                "text": "8 mg q8h PRN",
                "orderSentence": "Ondansetron 8 mg q8h PRN IV/PO"
              }
            ],
            "route": "IV/PO",
            "instructions": "4-8 mg IV/PO q6-8h PRN",
            "orderSentence": "Ondansetron 4 mg q6h PRN IV/PO"
          },
          "contraindications": "QT prolongation",
          "monitoring": "QTc if repeated dosing",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Acetaminophen",
          "route": "PO/IV",
          "indication": "Fever, mild pain",
          "dosing": {
            "doseOptions": [
              {
                "text": "650 mg q6h",
                "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
              },
              {
                "text": "1000 mg q6h",
                "orderSentence": "Acetaminophen 1000 mg q6h PO/IV"
              }
            ],
            "route": "PO/IV",
            "instructions": "650-1000 mg PO/IV q6h; max 4 g/day (3 g if hepatic impairment)",
            "orderSentence": "Acetaminophen 650 mg q6h PO/IV"
          },
          "contraindications": "Severe hepatic impairment",
          "monitoring": "LFTs if prolonged use",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        }
      ],
      "Treatment of GBS Variants": [
        {
          "item": "IVIg (Miller Fisher)",
          "route": "IV",
          "indication": "Miller Fisher syndrome",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg/day x 5 days",
                "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
              }
            ],
            "route": "IV",
            "instructions": "Same as standard GBS; benefit less clear for pure MFS without weakness",
            "orderSentence": "IVIg (Miller Fisher) 0.4 g/kg/day x 5 days IV"
          },
          "contraindications": "IgA deficiency",
          "monitoring": "Renal function, infusion reactions",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Observation only (MFS)",
          "route": "—",
          "indication": "Pure MFS (mild)",
          "dosing": {
            "doseOptions": [
              {
                "text": "N/A",
                "orderSentence": "Observation only (MFS) N/A —"
              }
            ],
            "route": "—",
            "instructions": "Consider observation without immunotherapy for pure MFS with mild symptoms and no limb weakness",
            "orderSentence": "Observation only (MFS) N/A —"
          },
          "contraindications": "If weakness present, treat",
          "monitoring": "Serial neuro exam, FVC",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Refractory/Treatment Failure": [
        {
          "item": "Second course IVIg",
          "route": "IV",
          "indication": "Treatment-related fluctuation",
          "dosing": {
            "doseOptions": [
              {
                "text": "0.4 g/kg/day x 5 days",
                "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
              }
            ],
            "route": "IV",
            "instructions": "Consider if deterioration during/after IVIg or PLEX; typically 2-3 weeks after first course",
            "orderSentence": "Second course IVIg 0.4 g/kg/day x 5 days IV"
          },
          "contraindications": "IgA deficiency",
          "monitoring": "Renal function",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "PLEX after IVIg failure",
          "route": "—",
          "indication": "IVIg non-response",
          "dosing": {
            "doseOptions": [
              {
                "text": "5 exchanges over 1-2 weeks",
                "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
              }
            ],
            "route": "—",
            "instructions": "Consider if no improvement 2-4 weeks post-IVIg; wait at least 2 weeks after IVIg completion",
            "orderSentence": "PLEX after IVIg failure 5 exchanges over 1-2 weeks —"
          },
          "contraindications": "Hemodynamic instability",
          "monitoring": "BP, coagulation",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        }
      ]
    },
    "Other Recommendations": {
      "Referrals & Consults": [
        {
          "item": "Neurology consult",
          "indication": "All suspected GBS",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Pulmonology consult",
          "indication": "Respiratory compromise",
          "ED": "URGENT",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Critical care consult",
          "indication": "FVC <30 mL/kg or declining",
          "ED": "URGENT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Physical therapy consult",
          "indication": "Mobility assessment, fall prevention",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Occupational therapy consult",
          "indication": "ADL assessment, adaptive equipment",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Speech therapy consult",
          "indication": "Bulbar weakness, dysphagia",
          "ED": "—",
          "HOSP": "URGENT",
          "OPD": "—",
          "ICU": "URGENT"
        },
        {
          "item": "Respiratory therapy",
          "indication": "Airway clearance, ventilator management",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—",
          "ICU": "STAT"
        },
        {
          "item": "Pain management consult",
          "indication": "Refractory neuropathic pain",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Physiatry/PM&R",
          "indication": "Rehabilitation planning",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        },
        {
          "item": "Social work",
          "indication": "Discharge planning, support resources",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "—",
          "ICU": "ROUTINE"
        }
      ],
      "Patient Instructions": [
        {
          "item": "Return if worsening weakness or shortness of breath",
          "ED": "STAT",
          "HOSP": "—",
          "OPD": "STAT"
        },
        {
          "item": "Fall precautions due to weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Do not drive until cleared by neurology",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Physical therapy exercises as prescribed",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Expect gradual recovery over weeks to months",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Report fevers, severe headache, or new symptoms",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "GBS Foundation resources (www.gbs-cidp.org)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ],
      "Lifestyle & Prevention": [
        {
          "item": "Aspiration precautions if bulbar weakness",
          "ED": "STAT",
          "HOSP": "STAT",
          "OPD": "—"
        },
        {
          "item": "DVT prevention: early mobilization when safe",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—"
        },
        {
          "item": "Skin breakdown prevention: frequent repositioning",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "STAT"
        },
        {
          "item": "Bladder care: monitor for retention",
          "ED": "—",
          "HOSP": "STAT",
          "OPD": "—"
        },
        {
          "item": "Energy conservation techniques",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        },
        {
          "item": "Gradual return to activities as tolerated",
          "ED": "—",
          "HOSP": "—",
          "OPD": "ROUTINE"
        },
        {
          "item": "Avoid vaccinations during acute illness (discuss timing with neurologist for future)",
          "ED": "—",
          "HOSP": "ROUTINE",
          "OPD": "ROUTINE"
        }
      ]
    }
  },
  "differential": [
    {
      "diagnosis": "Myasthenia gravis",
      "features": "Fatigable weakness, ptosis, diplopia; reflexes preserved",
      "tests": "AChR/MuSK antibodies, repetitive nerve stimulation, edrophonium test"
    },
    {
      "diagnosis": "Transverse myelitis",
      "features": "Sensory level, bowel/bladder dysfunction early, UMN signs",
      "tests": "MRI spine with contrast, CSF"
    },
    {
      "diagnosis": "Spinal cord compression",
      "features": "Sensory level, UMN signs below lesion, back pain",
      "tests": "MRI spine emergent"
    },
    {
      "diagnosis": "Botulism",
      "features": "Descending paralysis, pupil involvement, GI symptoms",
      "tests": "Stool/serum toxin assay, EMG (incremental response)"
    },
    {
      "diagnosis": "Poliomyelitis/West Nile",
      "features": "Asymmetric weakness, fever, CSF pleocytosis",
      "tests": "CSF PCR, serology"
    },
    {
      "diagnosis": "Tick paralysis",
      "features": "Recent tick exposure, ascending paralysis",
      "tests": "Physical exam (find tick), rapid improvement with tick removal"
    },
    {
      "diagnosis": "Critical illness polyneuropathy",
      "features": "ICU setting, sepsis, prolonged weakness",
      "tests": "EMG/NCS, clinical context"
    },
    {
      "diagnosis": "Hypokalemic periodic paralysis",
      "features": "Episodic weakness, low K+ during attacks",
      "tests": "Serum K+ during attack, genetic testing"
    },
    {
      "diagnosis": "Acute porphyria",
      "features": "Abdominal pain, psychiatric symptoms, motor neuropathy",
      "tests": "Urine porphyrins, ALA, PBG"
    },
    {
      "diagnosis": "Heavy metal poisoning",
      "features": "Exposure history, other systemic symptoms",
      "tests": "Heavy metal levels"
    },
    {
      "diagnosis": "Diphtheria",
      "features": "Pharyngitis, palatal weakness, cardiac involvement",
      "tests": "Throat culture, toxin assay"
    },
    {
      "diagnosis": "HIV-associated neuropathy",
      "features": "Risk factors, may have CSF pleocytosis",
      "tests": "HIV testing"
    },
    {
      "diagnosis": "CIDP",
      "features": "Chronic course (>8 weeks), relapsing",
      "tests": "Clinical course, EMG/NCS, CSF"
    }
  ],
  "evidence": [
    {
      "recommendation": "IVIg or PLEX equally effective for GBS",
      "evidenceLevel": "Class I, Level A",
      "source": "[Hughes et al. Cochrane 2014](https://pubmed.ncbi.nlm.nih.gov/25238327/)"
    },
    {
      "recommendation": "IVIg 0.4 g/kg x 5 days standard dosing",
      "evidenceLevel": "Class I, Level A",
      "source": "[van der Meché et al. NEJM 1992](https://pubmed.ncbi.nlm.nih.gov/1557426/)"
    },
    {
      "recommendation": "PLEX effective within 4 weeks of onset",
      "evidenceLevel": "Class I, Level A",
      "source": "[Raphaël et al. Cochrane 2012](https://pubmed.ncbi.nlm.nih.gov/22786476/)"
    },
    {
      "recommendation": "Combined IVIg + PLEX not superior",
      "evidenceLevel": "Class I, Level A",
      "source": "[Plasma Exchange/Sandoglobulin GBS Trial Group 1997](https://pubmed.ncbi.nlm.nih.gov/9008066/)"
    },
    {
      "recommendation": "Corticosteroids ineffective in GBS",
      "evidenceLevel": "Class I, Level A",
      "source": "[Hughes et al. Cochrane 2016](https://pubmed.ncbi.nlm.nih.gov/27749928/)"
    },
    {
      "recommendation": "FVC and NIF for respiratory monitoring",
      "evidenceLevel": "Class II, Level B",
      "source": "[Lawn et al. Ann Neurol 2001](https://pubmed.ncbi.nlm.nih.gov/11456310/)"
    },
    {
      "recommendation": "Anti-GQ1b associated with Miller Fisher",
      "evidenceLevel": "Class II, Level B",
      "source": "[Chiba et al. Ann Neurol 1992](https://pubmed.ncbi.nlm.nih.gov/1637140/)"
    },
    {
      "recommendation": "Campylobacter most common antecedent",
      "evidenceLevel": "Class II, Level B",
      "source": "[Jacobs et al. Neurology 1998](https://pubmed.ncbi.nlm.nih.gov/9710014/)"
    },
    {
      "recommendation": "Early IVIg (within 2 weeks) improves outcomes",
      "evidenceLevel": "Class II, Level B",
      "source": "[van Koningsveld et al. Lancet Neurol 2004](https://pubmed.ncbi.nlm.nih.gov/15261607/)"
    },
    {
      "recommendation": "20/30/40 rule for intubation",
      "evidenceLevel": "Class III, Level C",
      "source": "[Wijdicks & Lawn. Neurology 1999](https://pubmed.ncbi.nlm.nih.gov/10591488/)"
    }
  ],
  "monitoring": [
    {
      "item": "Forced vital capacity (FVC)",
      "frequency": "q4-6h initially; q2h if declining",
      "action": "Intubate if <20 mL/kg or >30% decline",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Negative inspiratory force (NIF)",
      "frequency": "q4-6h initially; q2h if declining",
      "action": "Intubate if weaker than -30 cmH2O",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Oxygen saturation",
      "frequency": "Continuous",
      "action": "Supplement oxygen, consider intubation",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Heart rate",
      "frequency": "Continuous",
      "action": "Treat bradycardia <50 or tachy >120",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Blood pressure",
      "frequency": "q1-4h",
      "action": "Treat hypo/hypertension",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Neurological exam (strength)",
      "frequency": "q4-8h",
      "action": "Escalate care if worsening",
      "ED": "STAT",
      "HOSP": "STAT",
      "OPD": "ROUTINE",
      "ICU": "STAT"
    },
    {
      "item": "Swallow function",
      "frequency": "Daily if bulbar symptoms",
      "action": "NPO, NG tube if unsafe",
      "ED": "—",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Urine output",
      "frequency": "q4-8h",
      "action": "Bladder scan, catheterize if needed",
      "ED": "—",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Renal function",
      "frequency": "Daily during IVIg",
      "action": "Hold IVIg, hydrate if rising",
      "ED": "—",
      "HOSP": "STAT",
      "OPD": "—",
      "ICU": "STAT"
    },
    {
      "item": "Skin integrity",
      "frequency": "q shift",
      "action": "Reposition, pressure relief",
      "ED": "—",
      "HOSP": "ROUTINE",
      "OPD": "—",
      "ICU": "ROUTINE"
    },
    {
      "item": "Bowel function",
      "frequency": "Daily",
      "action": "Bowel regimen if constipated",
      "ED": "—",
      "HOSP": "ROUTINE",
      "OPD": "—",
      "ICU": "ROUTINE"
    }
  ],
  "disposition": [
    {
      "disposition": "**ICU admission**",
      "criteria": "FVC <30 mL/kg; NIF weaker than -40 cmH2O; rapid progression; autonomic instability; bulbar dysfunction; need for intubation"
    },
    {
      "disposition": "**Step-down/telemetry**",
      "criteria": "Stable FVC >30 mL/kg; improving or stable exam; no autonomic instability; on telemetry monitoring"
    },
    {
      "disposition": "**General floor**",
      "criteria": "Mild weakness (ambulatory); stable FVC >40 mL/kg; no bulbar symptoms; no autonomic dysfunction"
    },
    {
      "disposition": "**Acute rehabilitation**",
      "criteria": "Medically stable; significant residual weakness requiring intensive therapy; FVC stable >25 mL/kg"
    },
    {
      "disposition": "**Discharge home**",
      "criteria": "Ambulatory or near-ambulatory; stable >48-72 hours; adequate home support; outpatient PT arranged; no respiratory compromise"
    },
    {
      "disposition": "**Skilled nursing facility**",
      "criteria": "Unable to participate in intensive rehab; requires ongoing nursing care; medically stable"
    }
  ]
}